Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
Company announcement – No. 38 / 2026 Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Zealand Pharma will receive USD 100 million for the sale of its…
Zealand Pharma Announces Financial Results for the First Half of 2026
Company announcement – No. 39 / 2026 Zealand Pharma Announces Financial Results for the First Half of 2026 A landmark first half defined by key milestones delivered for leading obesity assets, and a continued momentum building across all…
Pharma firms obliged to make medicines even if unprofitable - Opinion
Man buys medicine with the help of a pharmacy sales person in Chongqing municipality, Southwest China, July 21, 2014. [Photo/IC] AFTER MEDIA REPORTS about a shortage, even in some big hospitals, of mercapatopurinem, a medication used to treat…
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript
Wednesday, Aug. 5, 2026 at 8 a.m. ET Chief Executive Officer and Chairman of the Board - Pablo Legorreta Executive Vice President, Head of Research and Investments - Marshall Urist Chairman, Partnering and Investments - Christopher Hite Executive…
Why Revolution Medicines May Be Big Pharma's Next Takeover Target
RVMD has surged 492% over one year on daraxonrasib's landmark pancreatic cancer data showing 13.2 versus 6.7 months median overall survival. MRK ranks as the most likely acquirer, with Keytruda's patent cliff mounting pressure and CEO Robert Davis…
The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is
The iShares Core High Dividend ETF (NYSEARCA:HDV) leans hard on two sectors to fund its payout. Energy and pharma names account for the top four holdings, combining for 25.96% of net assets. With HDV up 19.66% year-to-date and yielding roughly 3%…
FY2026 EPS Estimates for Innate Pharma Reduced by Analyst
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Free Report) - Equities researchers at HC Wainwright dropped their FY2026 EPS estimates for shares of Innate Pharma in a note issued to investors on Monday, August 10th. HC Wainwright analyst S.
India pharma exports rise 6.8% to $8.1 billion in Q1 FY27; vaccine shipments jump 36%
India's pharmaceutical exports rose 6.80 per cent to $8.10 billion in the first quarter of FY27, with vaccine shipments surging 35.68 per cent and bulk drugs and drug intermediates growing 13.84 per cent, according to data released by the…
Avalyn Pharma (NASDAQ:AVLN) Hits New 52-Week High Following Better-Than-Expected Earnings
Shares of Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) reached a new 52-week high during mid-day trading on Thursday following a better than expected earnings announcement. The company traded as high as $39.99 and last traded at $37.38, with…
Royalty Pharma PLC $RPRX Stake Boosted by Handelsbanken Fonder AB
Handelsbanken Fonder AB lifted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 28.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 557,028 shares of the…
Avalyn Pharma (NASDAQ:AVLN) Trading Up 8.2% Following Better-Than-Expected Earnings
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares were up 8.2% during mid-day trading on Wednesday following a better than expected earnings announcement. The company traded as high as $39.04 and last traded at $38.35. Approximately 87,139…
BridgeBio Pharma (NASDAQ:BBIO) Given New $106.00 Price Target at Canaccord Genuity Group
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target increased by stock analysts at Canaccord Genuity Group from $104.00 to $106.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm…
BTIG Research Issues Positive Forecast for Innate Pharma (NASDAQ:IPHA) Stock Price
Innate Pharma (NASDAQ:IPHA - Get Free Report) had its price target hoisted by equities researchers at BTIG Research from $8.00 to $9.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a 'buy' rating on the…
Royalty Pharma PLC $RPRX Shares Sold by Wedge Capital Management L L P NC
Wedge Capital Management L L P NC lowered its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.5% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 770,422…
Electrification In Life Sciences: More Than A Power Upgrade
In the life sciences industry, electrification is often framed as a carbon reduction tactic. It makes sense. By changing processes, systems or pieces of equipment that burn fossil fuels to ones that consume electricity, organizations will see an…
Receive a Daily briefing on Pharma Industry News
Get Started